{"id":"bupivacaine-meloxicam","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions"},{"rate":null,"effect":"Gastrointestinal effects (meloxicam component)"},{"rate":null,"effect":"Systemic toxicity from local anesthetic (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bupivacaine is a long-acting local anesthetic that blocks sodium channels in nerve fibers, preventing pain signal transmission. Meloxicam is an NSAID that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin-mediated inflammation. The combination aims to provide both immediate local anesthesia and sustained anti-inflammatory effects for pain management.","oneSentence":"Bupivacaine-Meloxicam is a combination of a local anesthetic and a nonsteroidal anti-inflammatory drug designed to provide prolonged pain relief and reduce inflammation at the injection site.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:04.822Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Local anesthesia and pain relief in surgical or procedural settings"},{"name":"Post-operative pain management"}]},"trialDetails":[{"nctId":"NCT03237481","phase":"PHASE3","title":"Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-07-31","conditions":"Postoperative Pain","enrollment":418},{"nctId":"NCT03015532","phase":"PHASE2","title":"Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-01-13","conditions":"Postoperative Pain","enrollment":285},{"nctId":"NCT02689258","phase":"PHASE2","title":"Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2016-02-23","conditions":"Postoperative Pain","enrollment":277},{"nctId":"NCT03011333","phase":"PHASE2","title":"Phase 2B Upper Extremity Nerve Block Study","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-01-14","conditions":"Postoperative Pain","enrollment":243},{"nctId":"NCT03295721","phase":"PHASE3","title":"Bunionectomy Study for Postoperative Analgesia (EPOCH 1)","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2017-10-24","conditions":"Postoperative Pain","enrollment":412},{"nctId":"NCT03718039","phase":"PHASE2","title":"Phase 2 Bunionectomy HTX-011 Administration Study","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2018-10-24","conditions":"Postoperative Pain","enrollment":78},{"nctId":"NCT03695367","phase":"PHASE2","title":"Phase 2 Herniorrhaphy Study for Opioid Elimination","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2018-10-01","conditions":"Postoperative Pain","enrollment":63},{"nctId":"NCT02504580","phase":"PHASE2","title":"Pilot Herniorrhaphy Study for Postoperative Analgesia","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2015-07","conditions":"Postoperative Pain","enrollment":463},{"nctId":"NCT03974932","phase":"PHASE3","title":"Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2019-06-05","conditions":"Analgesia","enrollment":116},{"nctId":"NCT07430085","phase":"PHASE4","title":"Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA","status":"NOT_YET_RECRUITING","sponsor":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","startDate":"2026-01-31","conditions":"Periarticular Block, Osteoarthritis (OA), Osteoarthritis (OA) of the Knee","enrollment":150},{"nctId":"NCT02762929","phase":"PHASE2","title":"Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2016-05","conditions":"Postoperative Pain, Bunions","enrollment":430},{"nctId":"NCT07280195","phase":"PHASE4","title":"ZYNRELEF vs Continuous Catheter for Pain Management Following Shoulder Arthroplasty","status":"ENROLLING_BY_INVITATION","sponsor":"Washington University School of Medicine","startDate":"2026-02-14","conditions":"Total Shoulder Arthroplasty, Pain Management","enrollment":86},{"nctId":"NCT07216586","phase":"PHASE4","title":"Zynrelef Versus Adductor Canal Block","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-06","conditions":"Knee Osteoarthritis, Arthritis Knee","enrollment":120},{"nctId":"NCT05188053","phase":"PHASE4","title":"Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-03-11","conditions":"Total Knee Arthroplasty","enrollment":209},{"nctId":"NCT05644496","phase":"PHASE4","title":"ZYNRELEF for Pain Management in Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2023-03-09","conditions":"Post Operative Pain, Osteoarthritis, Knee","enrollment":242},{"nctId":"NCT06349772","phase":"EARLY_PHASE1","title":"Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy","status":"RECRUITING","sponsor":"Texas Tech University Health Sciences Center","startDate":"2024-11-01","conditions":"Post Operative Pain","enrollment":130},{"nctId":"NCT04176783","phase":"NA","title":"Opioid-Free Orthopaedic Surgery","status":"COMPLETED","sponsor":"OrthoCarolina Research Institute, Inc.","startDate":"2018-03-26","conditions":"Pain Management","enrollment":511},{"nctId":"NCT05672784","phase":"NA","title":"Genicular Nerve Block Versus Its Combination With Infiltration Between Popliteal Artery and Capsule of Posterior Knee","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2022-11-05","conditions":"Postoperative Pain","enrollment":63},{"nctId":"NCT05702827","phase":"PHASE3","title":"Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery","status":"COMPLETED","sponsor":"TriHealth Inc.","startDate":"2023-01-23","conditions":"Stress Urinary Incontinence, Surgical Incision, Pain Vulva","enrollment":148},{"nctId":"NCT05252858","phase":"NA","title":"A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery","status":"COMPLETED","sponsor":"Jacques E. Chelly","startDate":"2022-03-21","conditions":"Opioid Use, Pain, Post Operative","enrollment":79},{"nctId":"NCT06109415","phase":"PHASE4","title":"A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2021-10-20","conditions":"Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia","enrollment":30},{"nctId":"NCT06109428","phase":"PHASE4","title":"A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2021-10-12","conditions":"Analgesia","enrollment":30},{"nctId":"NCT05109312","phase":"PHASE4","title":"A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.","status":"UNKNOWN","sponsor":"Heron Therapeutics","startDate":"2021-10-12","conditions":"Analgesia","enrollment":90},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT04911062","phase":"PHASE2","title":"HTX-011 in Spinal Surgery","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2022-04-07","conditions":"Post-Operative Pain, Lumbar Laminectomy","enrollment":32},{"nctId":"NCT03922048","phase":"PHASE2","title":"Pediatric Postoperative Analgesia Herniorrhaphy Study","status":"WITHDRAWN","sponsor":"Heron Therapeutics","startDate":"2023-07","conditions":"Analgesia","enrollment":""},{"nctId":"NCT05863221","phase":"PHASE4","title":"ZYNRELEF® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy","status":"UNKNOWN","sponsor":"Dr. Yannis Raftopoulos","startDate":"2023-05-09","conditions":"Post Operative Pain, Acute, Bariatric Surgery Candidate, Postoperative Pain","enrollment":120},{"nctId":"NCT05751421","phase":"PHASE3","title":"Pain Relief After PrimaryTKA","status":"UNKNOWN","sponsor":"Rothman Institute Orthopaedics","startDate":"2023-02-28","conditions":"Pain, Postoperative","enrollment":60},{"nctId":"NCT04421196","phase":"NA","title":"Opioid-free Total Hip Arthroplasty","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2022-09-15","conditions":"Hip Osteoarthritis","enrollment":""},{"nctId":"NCT01335542","phase":"PHASE4","title":"Analgesia After Total Knee Arthroplasty: Peri-Articular Injection Versus Epidural + Femoral Nerve Blockade","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2010-03","conditions":"Readiness to Discharge","enrollment":91},{"nctId":"NCT03955211","phase":"PHASE2","title":"HTX-011 Administration Study in Planned Caesarean Section Procedure","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2019-06-24","conditions":"Analgesia","enrollment":25},{"nctId":"NCT03907176","phase":"PHASE3","title":"Herniorrhaphy Study for Opioid Elimination","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2019-04-05","conditions":"Analgesia","enrollment":115},{"nctId":"NCT03540030","phase":"PHASE4","title":"Opioid-Free Shoulder Arthroplasty","status":"COMPLETED","sponsor":"OrthoCarolina Research Institute, Inc.","startDate":"2016-09","conditions":"Opioid Use, Shoulder Osteoarthritis, Avascular Necrosis","enrollment":86},{"nctId":"NCT04538391","phase":"NA","title":"Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2019-03-03","conditions":"Cesarean Section Pain","enrollment":105},{"nctId":"NCT02403687","phase":"","title":"Prospective Analgesic Compound Efficacy (PACE) Study","status":"COMPLETED","sponsor":"Express Specialty Pharmacy","startDate":"2015-06","conditions":"Arthritis, Tendonitis, Gout","enrollment":300},{"nctId":"NCT02471898","phase":"PHASE2","title":"A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2015-06","conditions":"Analgesia","enrollment":71}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Bupivacaine-Meloxicam","genericName":"Bupivacaine-Meloxicam","companyName":"TriHealth Inc.","companyId":"trihealth-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bupivacaine-Meloxicam is a combination of a local anesthetic and a nonsteroidal anti-inflammatory drug designed to provide prolonged pain relief and reduce inflammation at the injection site. Used for Local anesthesia and pain relief in surgical or procedural settings, Post-operative pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}